Clinical Trial Update: Effects of Huperzine A in Treatment of Moderate to Severe TBI [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating huperzine A for moderate to severe traumatic brain injury was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Huperzine A (Huperzine A)

Snippet

Sponsor: Spaulding Rehabilitation Hospital | Conditions: Traumatic Brain Injury | Phase 2 | Status: TERMINATED | Results posted: 2019-10-07